3,5-dihydroxyphenylglycine has been researched along with 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide in 2 studies
| Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) | Trials (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) | Recent Studies (post-2010) (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) |
|---|---|---|---|---|---|
| 301 | 1 | 61 | 60 | 0 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Conn, PJ; de Paulis, T; Goudet, C; Hemstapat, K; Nong, Y; Pin, JP | 1 |
| Hsu, KS; Huang, CC; Lee, CC; Liang, YC | 1 |
2 other study(ies) available for 3,5-dihydroxyphenylglycine and 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide
| Article | Year |
|---|---|
Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
Topics: Allosteric Regulation; Allosteric Site; Animals; Benzamides; Binding, Competitive; Cell Line; Drug Synergism; Glycine; Humans; Male; Mutation; Neurons; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Substantia Nigra; Substrate Specificity; Subthalamic Nucleus | 2007 |
Cocaine Withdrawal Impairs mGluR5-Dependent Long-Term Depression in Nucleus Accumbens Shell Neurons of Both Direct and Indirect Pathways.
Topics: Animals; Benzamides; Chromones; Cocaine; Cocaine-Related Disorders; Dopaminergic Neurons; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Genes, Reporter; Glycine; Imidazoles; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nucleus Accumbens; Pyrazoles; Pyridazines; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D1; Receptors, Dopamine D2; Resorcinols; Substance Withdrawal Syndrome | 2015 |